Arkansas

Motor Vehicle Crashes Mortality

Healthy People 2010 Objective: Reduce deaths caused by motor vehicle crashes

Rates per 100,000
National Data Baseline
(1999)
Final
(2007)
Numeric
Change
2010
Target
15- to 24- year-olds
25.6
24.1
-1.5

 

State Data
All the tables below contain data available for this State and this objective.

Rates per 100,000
Age Baseline
(1999)
Final
(2007)
Numeric
Change
Ages 15-19
39.98
42.67
2.69
Ages 20-24
33.96
47.74
13.78
Ages 15-24
37.13
45.13
8.00
 
Rates per 100,000
Gender Baseline
(1999)
Final
(2007)
Numeric
Change
Males 15-24
52.73
56.92
4.19
Females 15-24
20.93
32.7
11.77
 
Rates per 100,000
Race/Ethnicity Baseline
(1999)
Final
(2007)
Numeric
Change
White (non Hispanic) 15-24
41.94
48.63
6.69
Black (non Hispanic) 15-24
22.06*
31.25
9.19
American Indian/Alaskan Native (non Hispanic) 15-24
X
28.26*
X
Asian/Pacific Islander (non Hispanic)15-24
48.92*
24.00*
-24.92
Hispanic 15-24
30.02*
58.77*
28.75
 
Rates per 100,000
Race/Ethnicity by Gender Baseline
(1999)
Final
(2007)
Numeric
Change
White (non Hispanic) Males 15-24
58.42
61.29
2.87
White (non Hispanic) Females 15-24
24.83
35.29
10.46
Black (non Hispanic) Males 15-24
34.3*
32.21*
-2.09
Black (non Hispanic) Females 15-24
10.21*
30.27*
20.06
American Indian/Alaskan Native (non Hispanic) Males 15-24
X
56.24*
X
American Indian/Alaskan Native (non Hispanic) Females 15-24
X
0.00*
X
Asian/Pacific Islander (non Hispanic) Males 15-24
95.69*
45.72*
-49.97
Asian/Pacific Islander (non Hispanic) Females 15-24
9*
0.00*
-9.00
Hispanic Males 15-24
40.5*
90.62*
50.12
Hispanic Females 15-24
14.76*
20.04*
5.28
 

Source: WISQARS Fatal Causes of Deaths (using data collected by National Vital Statistics System), National Center for Injury Prevention and Control, Centers for Disease Prevention and Control

*Based on 20 or fewer number of deaths; use with caution

X = In the Baseline or Final columns, “X” represents zero deaths for a subgroup; in the Numeric Change column, “X” means that a number cannot be generated to show the change between baseline and Final.